Back to search
FDAFDA · Food and drugs·Recall number D-0112-2025

Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelphia, PA 19136, NDC: 0527-4661-37

Published December 11, 2024 · Recall initiated: October 25, 2024

Summary

FDA records drug Class II recall D-0112-2025, published December 11, 2024 and initiated October 25, 2024. Recalling firm: Lannett Company Inc.; Status: Terminated; Reported quantity: 1608 bottles; Lot: Lot: 23274856A, Exp 04/30/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.

What to do

Voluntary: Firm initiated · Letter

Get an email if LISDEXAMFETAMINE DIMESYLATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LISDEXAMFETAMINE DIMESYLATE
Manufacturer
Lannett Company Inc.
Distributor
Nationwide in the USA
UPC
0305274664379
Lot
Lot: 23274856A, Exp 04/30/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelphia, PA 19136, NDC: 0527-4661-37 recalled?

Yes. FDA published recall D-0112-2025 on December 11, 2024. Reported hazard: Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LISDEXAMFETAMINE DIMESYLATE. UPC: 0305274664379.